Our findings call for the prioritisation of further trials into the efficacy and safety of doses of primaquine between @ mg/kg and @ mg/kg ( including the dose of @ mg/kg recently recommended by WHO ) , in view of the potential for widespread use of the drug to block malaria transmission .